BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28762896)

  • 1. Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).
    Appleton JP; Scutt P; Dixon M; Howard H; Haywood L; Havard D; Hepburn T; England T; Sprigg N; Woodhouse LJ; Wardlaw JM; Montgomery AA; Pocock S; Bath PM;
    Int J Stroke; 2019 Feb; 14(2):191-206. PubMed ID: 28762896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
    RIGHT-2 Investigators
    Lancet; 2019 Mar; 393(10175):1009-1020. PubMed ID: 30738649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline characteristics of the 1149 patients recruited into the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) randomized controlled trial.
    Bath PM; Scutt P; Appleton JP; Dixon M; Woodhouse LJ; Wardlaw JM; Sprigg N
    Int J Stroke; 2019 Apr; 14(3):298-305. PubMed ID: 30475165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
    van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB;
    Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical analysis plan for the 'Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)'.
    Scutt P; Appleton JP; Dixon M; Woodhouse LJ; Sprigg N; Wardlaw JM; Montgomery AA; Pocock S; Bath PM
    Eur Stroke J; 2018 Jun; 3(2):193-196. PubMed ID: 31008350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial.
    Bath PM; Woodhouse LJ; Krishnan K; Appleton JP; Anderson CS; Berge E; Cala L; Dixon M; England TJ; Godolphin PJ; Hepburn T; Mair G; Montgomery AA; Phillips SJ; Potter J; Price CI; Randall M; Robinson TG; Roffe C; Rothwell PM; Sandset EC; Sanossian N; Saver JL; Siriwardena AN; Venables G; Wardlaw JM; Sprigg N
    Stroke; 2019 Nov; 50(11):3064-3071. PubMed ID: 31587658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824).
    Ankolekar S; Fuller M; Cross I; Renton C; Cox P; Sprigg N; Siriwardena AN; Bath PM
    Stroke; 2013 Nov; 44(11):3120-8. PubMed ID: 24003041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-hospital transdermal glyceryl trinitrate in patients with stroke mimics: data from the RIGHT-2 randomised-controlled ambulance trial.
    Tunnage B; Woodhouse LJ; Dixon M; Anderson C; Ankolekar S; Appleton J; Cala L; England T; Krishnan K; Havard D; Mair G; Muir K; Phillips S; Potter J; Price C; Randall M; Robinson TG; Roffe C; Sandset E; Siriwardena N; Scutt P; Wardlaw JM; Sprigg N; Bath PM;
    BMC Emerg Med; 2022 Jan; 22(1):2. PubMed ID: 35012462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time intervals and distances travelled for prehospital ambulance stroke care: data from the randomised-controlled ambulance-based Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2).
    Dixon M; Appleton JP; Scutt P; Woodhouse LJ; Haywood LJ; Havard D; Williams J; Siriwardena AN; Bath PM;
    BMJ Open; 2022 Nov; 12(11):e060211. PubMed ID: 36410799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122).
    ENOS Trial Investigators
    Int J Stroke; 2006 Nov; 1(4):245-9. PubMed ID: 18706028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.
    ENOS Trial Investigators
    Lancet; 2015 Feb; 385(9968):617-628. PubMed ID: 25465108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerin Patch (MR ASAP): study protocol for a randomised controlled trial.
    van den Berg SA; Dippel DWJ; Hofmeijer J; Fransen PSS; Caminada K; Siegers A; Kruyt ND; Kerkhoff H; de Leeuw FE; Nederkoorn PJ; van der Worp HB;
    Trials; 2019 Jun; 20(1):383. PubMed ID: 31242931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial.
    Appleton JP; Woodhouse LJ; Anderson CS; Ankolekar S; Cala L; Dixon M; England TJ; Krishnan K; Mair G; Muir KW; Potter J; Price CI; Randall M; Robinson TG; Roffe C; Sandset EC; Saver JL; Shone A; Siriwardena AN; Wardlaw JM; Sprigg N; Bath PM;
    Stroke Vasc Neurol; 2024 Feb; 9(1):38-49. PubMed ID: 37290930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial.
    Woodhouse L; Scutt P; Krishnan K; Berge E; Gommans J; Ntaios G; Wardlaw J; Sprigg N; Bath PM;
    Stroke; 2015 Nov; 46(11):3194-201. PubMed ID: 26463698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial.
    Krishnan K; Scutt P; Woodhouse L; Adami A; Becker JL; Cala LA; Casado AM; Chen C; Dineen RA; Gommans J; Koumellis P; Christensen H; Collins R; Czlonkowska A; Lees KR; Ntaios G; Ozturk S; Phillips SJ; Sprigg N; Szatmari S; Wardlaw JM; Bath PM;
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1017-1026. PubMed ID: 26853137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.
    Woodhouse LJ; Appleton JP; Ankolekar S; England TJ; Mair G; Muir K; Price CI; Pocock S; Randall M; Robinson TG; Roffe C; Sandset EC; Saver JL; Siriwardena AN; Sprigg N; Wardlaw JM; Bath PM;
    BMJ Neurol Open; 2023; 5(1):e000424. PubMed ID: 37564156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis.
    Krishnan K; Scutt P; Woodhouse L; Adami A; Becker JL; Berge E; Cala LA; Casado AM; Caso V; Chen C; Christensen H; Collins R; Czlonkowska A; Dineen RA; Gommans J; Koumellis P; Lees KR; Ntaios G; Ozturk S; Phillips SJ; Pocock SJ; de Silva A; Sprigg N; Szatmari S; Wardlaw JM; Bath PM
    Stroke; 2016 Jan; 47(1):44-52. PubMed ID: 26645254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.
    Bath PM; Houlton A; Woodhouse L; Sprigg N; Wardlaw J; Pocock S;
    Int J Stroke; 2014 Apr; 9(3):372-4. PubMed ID: 24588789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke.
    Bath PM; Pathansali R; Iddenden R; Bath FJ
    Cerebrovasc Dis; 2001; 11(3):265-72. PubMed ID: 11306778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis.
    Appleton JP; Woodhouse LJ; Belcher A; Bereczki D; Berge E; Caso V; Chang HM; Christensen HK; Collins R; Gommans J; Laska AC; Ntaios G; Ozturk S; Sare GM; Szatmari S; Wang Y; Wardlaw JM; Sprigg N; Bath PM
    Stroke Vasc Neurol; 2019 Mar; 4(1):28-35. PubMed ID: 31105976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.